Viewing Study NCT02955160


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2026-01-07 @ 5:32 PM
Study NCT ID: NCT02955160
Status: COMPLETED
Last Update Posted: 2018-09-11
First Post: 2016-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-11-03
Start Date Type: ACTUAL
Primary Completion Date: 2017-08-01
Primary Completion Date Type: ACTUAL
Completion Date: 2017-08-01
Completion Date Type: ACTUAL
First Submit Date: 2016-11-02
First Submit QC Date: None
Study First Post Date: 2016-11-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-09-07
Last Update Post Date: 2018-09-11
Last Update Post Date Type: ACTUAL